BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13D/A filed Apr 2, 2026

Form type

SCHEDULE 13D/A

Filing date

Apr 2, 2026

Accession number

0000905148-26-001499

Filer

BridgeBio Pharma, Inc. (CIK 1743881)